No Data
Benchmark Co. Remains a Buy on Humacyte (HUMA)
Humacyte to Participate at Upcoming Investor Conferences in September
Both Retail Investors Who Control a Good Portion of Humacyte, Inc. (NASDAQ:HUMA) Along With Institutions Must Be Dismayed After Last Week's 14% Decrease
Humacyte(HUMA.US) Officer Sells US$5.72 Million in Common Stock
Humacyte Reports Positive Results From ATEV Treatment of Vascular Trauma in Ukraine
Humacyte Presents Positive Long-Term Results of ATEV in Treatment of Vascular Trauma in Military Setting From Ukraine Humanitarian Program
loading...
Flowerhill : 666